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 6 
Novelty statement 7 
The prevalence of type 2 diabetes (T2DM) is alarmingly high among ethnic minority groups in the 8 
United Kingdom (UK), about 3-5 times higher than White-British population. Particularly striking is 9 
the earlier onset of T2DM, which occurs some 10-12 years younger, with a significant proportion of 10 
cases being diagnosed before the age of 40 years. 11 
A wealth of literature exists aiming to understand how genetic, physiological, socio-economic and 12 
lifestyle factors contribute to ethnic inequalities in T2DM. Much of this evidence is drawn from the 13 
United States of America; the current review focuses on the UK context, in which there are distinctions 14 
in the demographic, social and healthcare system factors that contribute to the presentation and 15 
outcomes of T2DM. 16 
This review highlights a number of ways in which ethnicity impacts on the pathophysiology, 17 
presentation, complications and management of T2DM. Importantly it draws upon evidence from UK 18 
cohorts and recognises distinctions between UK cohorts and those residing in other regions. The focus 19 
on the UK context aims to provide practitioners with a greater understanding of T2DM in ethnic 20 
minority groups. 21 
 22 
  23 
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Abstract 24 
Type 2 diabetes (T2DM) is a major UK public health priority. Among ethnic minority communities the 25 
prevalence is alarmingly high, about 3-5 times higher than White-British population. Particularly 26 
striking is the earlier onset of T2DM, which occurs some 10-12 years younger, with a significant 27 
proportion of cases being diagnosed before the age of 40 years. This review focuses on the UK context 28 
and T2DM in adult populations, exploring the available evidence regarding the complex interplay of 29 
biological, lifestyle, social, clinical and healthcare system factors that are known to drive these 30 
disparities.  31 
  32 
3 
 
Introduction 33 
It is well documented that ethnic minority groups in the United Kingdom (UK) and worldwide suffer 34 
disproportionately from diabetes compared to non-minority populations (1, 2). This review will focus 35 
on type 2 diabetes (T2DM) as it is the burden of this disease that is most evident amongst ethnic minority 36 
populations, and it will focus on the UK context in which demographic, social and healthcare system 37 
factors contribute to the presentation and outcomes of T2DM being distinct to that of other regions.  38 
Ethnic Diversity in the United Kingdom 39 
The UK population is recognised for its growing diversity. In the most recent Census of England and 40 
Wales 14% of the population identified as from an ethnic minority background (Figure 1); whilst these 41 
figures are lower in Scotland (4%) and Northern Ireland (1.8%) all regions have seen significant growth 42 
of their minority communities over the last two decades. Half of the total minority population are of 43 
South Asian descent (Indian, Pakistani, Bangladeshi, or other Asian origin), around 25% are of Black, 44 
African, Caribbean or other Black descent, and there are smaller communities of Arab and other ethnic 45 
backgrounds (3). Growth in the diversity of the UK population is relatively recent compared to other 46 
regions, beginning mainly in response post-second world war appeals to citizens of Europe and the 47 
Commonwealth regions to move to the UK to assist with gaps in its labour market, including its public 48 
services such as the newly created National Health Service. This led to a large influx of labour in the 49 
1950s from a number of European nations (e.g. Hungary, Italy, Ireland and Poland) as well the 50 
Commonwealth nations of India, Pakistan and the Caribbean islands, particularly Jamaica. The 51 
symbolic starting point of mass migration from the Caribbean was the journey of almost 500 West 52 
Indians on the SS Empire Windrush from Kingston, Jamaica in June 1948. From the Indian 53 
subcontinent, the majority of immigrants arrived in Britain during the 1950s and 1960s and included 54 
Hindus from the Gujarat region of western India, Sikhs from the eastern Punjab region, and Muslims 55 
both from the west part of Pakistan and from East Pakistan (now Bangladesh). Migrants from the 56 
African continent form another significant proportion of the UK population; often from Commonwealth 57 
countries, such as Nigeria, Ghana and Kenya, the majority of migration from these countries has tended 58 
to be more recent, peaking around the 1980s and often in response to economic downturn post-59 
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independence. Asylum from civil unrest is another driver of recent migration to the UK from countries 60 
such as Somalia. Migrants from African nations currently form the largest growing ethnic minority 61 
group in the UK population, whilst growth of other ethnic minority populations is slowing (3). 62 
Ethnicity is a complex multidimensional construct that groups people who identify with each other 63 
through shared cultural traditions. Membership of an ethnic group tends to be defined by shared cultural 64 
heritage, ancestry, language, history, diet, religion or physical appearance (4). Ethnicity, therefore, 65 
should be self-defined, allowing the individual to assert their identity, although it is often established 66 
or confirmed through information on parental and grandparental origin (5). The term ‘ethnic minority 67 
group’ has traditionally described migrant communities, i.e. people with a different birth country to that 68 
in which they reside. However, it is now recognised that classifying ethnicity according to country of 69 
birth is inappropriate in many regions of the world where communities of 2nd and 3rd generation migrants 70 
live, and as such new terminologies, which capture ancestry rather than place of birth have been 71 
introduced e.g. Black-British and Asian-American. It is important to distinguish ethnicity from race or 72 
racial background, which is a cruder/simpler construct that uses physical traits, such as skin colour, to 73 
group people.  74 
Diabetes in Ethnic Minority Groups – the scale of the problem 75 
Diabetes is a major UK public health priority. Currently in the UK, 5.6% of the population or 3.7 million 76 
individuals have diagnosed diabetes but the true prevalence is thought to be nearer 7.4% when 77 
undiagnosed individuals are taken in to account (6). Among ethnic minority groups the prevalence is 78 
alarmingly high, about three to five times higher (Figure 2). Modelling of data from the London 79 
‘SABRE’ multi-ethnic cohort estimates that by age 80 years, 40-50% of South Asian and African-80 
Caribbean men and women will have T2DM, at least twice the proportion of their age-matched White-81 
European counterparts (7). Particularly striking is the earlier onset of T2DM; a recent analysis of UK 82 
primary care data showed the age of diagnosis to be 10-12 years younger on average in South Asians 83 
(46 ± 12 years) and Black African/Caribbeans (48 ± 12 years) compared to White-Europeans (58 ± 12 84 
years) (8). Furthermore, a significantly greater proportion of people from ethnic minority backgrounds 85 
develop T2DM before the age of 40 years compared to White-Europeans (Figure 3) (8). The significant 86 
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variability in diabetes prevalence within a given ethnic group between different environments (for 87 
example, indigenous versus diasporic communities) provides evidence that these disparities are driven 88 
by a complex interplay of biological, lifestyle, social, clinical and healthcare system factors. 89 
While this review will focus on adult T2DM, it is important to recognise that childhood T2DM is 90 
significantly more prevalent among children and adolescents from ethnic minority groups than children 91 
of White-European ancestry. The US SEARCH for Diabetes in Youth study, which recently reported a 92 
30.5% increase in T2DM amongst 10-19 year olds between 2001 and 2009, shows the disproportionate 93 
burden of T2DM among children from ethnic minority groups, with an estimated prevalence of 1.20 94 
per 1000 among American-Indian youth and 1.06 per 1000 among Black African-American youth 95 
compared to 0.17 per 1000 among White-American youth (9). In the UK it is estimated that South Asian 96 
children are 14 times more likely to develop T2DM than White-European children (10), which may be 97 
driven by higher body fat and central fat accumulation (11).  98 
Risk factors and aetiology of diabetes in ethnic minority groups 99 
Recognition of ethnic patterns of disease has led to extensive research investigating the roles of genetic, 100 
social and lifestyle factors in these inequalities.  101 
The contribution that genetic factors make to ethnic inequalities in T2DM is unclear. The majority of 102 
studies, focused on common variants, suggest there is no ethnic variation in the genetic architecture that 103 
confers an increased T2DM risk, however, large-scale genetic studies in non-White European 104 
populations are lacking (2, 12). 105 
Epidemiological evidence and migration studies that recognise different rates of disease within an 106 
ethnic group living in different environments or countries demonstrates the influence of non-genetic 107 
factors e.g. prevalence of T2DM is around 2% among Asian-Indians living in rural areas of India 108 
compared to around 8% among Asian-Indians living in urban India, and Asian-Indians living in the UK 109 
or other westernised countries, have about four times higher prevalence (13, 14). The comparison in 110 
populations of African ancestry is even more striking as it is estimated that African-Americans have a 111 
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prevalence of T2DM at least 12 times greater than that observed among indigenous African-Blacks (15-112 
18). 113 
Obesity represents one of the strongest contributors to the development of T2DM; around 90% of adults 114 
with T2DM are overweight or obese, and T2DM is five times more prevalent amongst adults with an 115 
obese body mass index (BMI) compared to those with a healthy weight (19). In the UK around 60% of 116 
adults are overweight or obese (BMI ≥25 kg/m2) and 25% are obese (BMI ≥30 kg/m2) (20). In some 117 
ethnic groups obesity rates are high, for example Black African/Caribbean women, but in others e.g. 118 
Black African/Caribbean men, the rates are no different to White-Europeans or the general population 119 
(Figure 4) (1). Recently a number of UK-based multi-ethnic cohort studies have identified that ethnic 120 
minority groups experience a higher risk of T2DM at lower levels of obesity than White-Europeans (8, 121 
21, 22). Modelling of UK Biobank data have demonstrated that T2DM prevalence in South Asian 122 
groups with a BMI of 22 kg/m2 is equivalent to T2DM prevalence in White groups with a BMI of 30 123 
kg/m2; while in Black African/Caribbean groups the equivalent BMI is 26 kg/m2, and in Chinese women 124 
and men it is 24 and 26 kg/m2, respectively (21). Data from The Health Improvement Network (THIN), 125 
a UK longitudinal general practice dataset, demonstrates that South Asians and Black 126 
African/Caribbeans have significantly higher probability of developing T2DM in the normal and 127 
overweight BMI categories, compared to White-Europeans and significantly more South Asians (38%) 128 
develop T2DM at a BMI below 30 kg/m2 than White-Europeans (26%) and Black African/Caribbeans 129 
(29%) (8). Emerging evidence from the Child Heart and Health Study in England (CHASE), in which 130 
ethnic patterns in adiposity have been assessed in UK South Asian, Black African/Caribbean and White-131 
European ethnicity, has shown higher levels of adiposity at any given BMI among South Asian children 132 
and lower or similar among Black African/Caribbean children compared to White-Europeans. These 133 
data suggest that BMI systematically underestimates adiposity in South Asians (23) and helps to explain 134 
why T2DM occurs at lower BMI cut-offs in South Asian communities. Drawn together this evidence 135 
suggests that conventional clinical definitions for obesity, that are derived from populations of White 136 
European descent (BMI ≥30 kg/m2; waist circumference ≥88 cm in women and ≥102 cm in men), may 137 
not be appropriate for screening diabetes risk in non-white groups. In response the World Health 138 
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Organisation (WHO) and International Diabetes Federation (IDF) have proposed Asian specific 139 
thresholds in which overweight is defined as a BMI >23 kg/m2 and obesity >27.5 kg/m2, with waist 140 
circumference cut-offs of 80 cm for Asian women and 90 cm for Asian men (24, 25), although there is 141 
concern that these may be too conservative and lower cut-offs should be introduced (26). Currently 142 
there is insufficient data to derive specific cut-offs for Black African/Caribbean men and women, 143 
therefore European thresholds remain in use with these communities. 144 
Ethnic differences in the pathophysiology of diabetes 145 
The main pathophysiological processes underlying T2DM development are well documented and focus 146 
on the role of obesity, visceral and ectopic fat accumulation, insulin resistance and insulin secretory 147 
failure (27). Originally insulin resistance was proposed as the principal abnormality, attributed to 148 
visceral fat accumulation and the resultant flow of free fatty acids into the portal vein and deposition of 149 
hepatic fat. Insulin resistance would subsequently lead to compensatory insulin hypersecretion to 150 
maintain normoglycaemia. At the point of ‘beta-cell exhaustion’ or ‘burn-out’, where the beta-cells are 151 
unable to secrete sufficient insulin, the state of frank hyperglycaemia develops. It is now understood 152 
that there is a heterogeneity in the relationship between insulin sensitivity and insulin secretion, in that 153 
glucose tolerance can be maintained even in the presence of severe insulin resistance if the beta-cell 154 
secretory capacity is able to balance the degree of insulin resistance. Conversely, an individual may 155 
become hyperglycaemic with a relatively low level of insulin resistance if they have a low beta-cell 156 
secretory capacity.  157 
There is a wealth of research investigating ethnic differences in the pathophysiology of T2DM. There 158 
is much debate as to whether the predominant mechanism in the development of T2DM differs 159 
according to ethnicity; much of the uncertainty comes from the contrast between methods used to 160 
measure these processes in large scale cohort/epidemiological studies compared to those used in 161 
detailed mechanistic investigations. In the UK SABRE cohort beta-cell function was lowest among 162 
Black African/Caribbean participants while South Asians showed more adverse measures of insulin 163 
resistance and higher calculated beta-cell function (7). While there is extensive evidence coming both 164 
from large-scale epidemiological studies and smaller detailed mechanistic investigations demonstrating 165 
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greater insulin resistance among South Asian populations compared to White-Europeans (28-35), there 166 
is also evidence that suggests South Asian populations are not characterised by more severe insulin 167 
resistance (36) and that progression of T2DM is more strongly linked to susceptibility of the beta-cells 168 
than insulin resistance (37-39). Detailed physiological studies in Black populations have also focused 169 
on the role of inadequate beta-cell function in the development of T2DM. An exaggerated insulin 170 
response to glucose stimulation in Blacks compared to other ethnic groups has been consistently 171 
reported, which is recognised to be driven by a combination of higher insulin secretion and lower 172 
hepatic insulin clearance (40, 41). Recent evidence has shown that by the point of frank T2DM there 173 
are greater failures in beta-cell insulin secretory capacity in Blacks but that these are still compensated 174 
for by reduced hepatic insulin clearance (42). It is important to note that there is a lack of longitudinal 175 
data in this field, therefore, it is still not possible to draw clear conclusions.  176 
Insulin resistance is closely associated with occurrence of the Metabolic Syndrome, defined as a 177 
clustering of metabolic derangements including abdominal obesity, dyslipidaemia (raised triglyceride 178 
and low high-density lipoprotein (HDL) concentrations), hypertension and dysglycaemia (25), which is 179 
known to increase the risk of T2DM and cardiovascular disease (43, 44). South Asian populations are 180 
recognised to exhibit many features of Metabolic Syndrome in the prediabetic and diabetic state, 181 
particularly central obesity and dyslipidaemia (45), however Black African/Caribbean populations have 182 
a distinct phenotype in which there is marked hypertension (46) but in the absence of dyslipidaemia or 183 
central obesity (47-49). These ethnic patterns in cardiometabolic risk are evident in early life, for 184 
example dyslipidaemia was found to be most prevalent among South Asian, and least prevalent among 185 
Black African/Caribbean children in the CHASE study (50).  186 
Increasing body fat content is linearly related to insulin resistance (51-54), however, it is now accepted 187 
that fat distribution, particularly abdominal/visceral fat, is a more sensitive predictor of insulin 188 
sensitivity than body mass index (BMI). Consistently in the literature South Asians are reported to have 189 
higher amounts of body fat for a given BMI and a higher risk of developing central obesity compared 190 
to White-Europeans despite similar or smaller body mass index values (55, 56). Evidence suggests that 191 
South Asians may be more prone to visceral fat deposition than White-Europeans or African-ancestry 192 
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groups, who develop less visceral obesity for a similar BMI (57), although the evidence for this is not 193 
always consistent (58) with the suggestion that visceral accumulation is more evident in men (59). There 194 
is a lot of interest in visceral fat in Black populations, who despite exhibiting markedly greater insulin 195 
resistance than White-Europeans have significantly less visceral fat (60). These differences are apparent 196 
as early as childhood/adolescence, indicating that these differences manifest early in life (61). While 197 
increased adiposity, particularly visceral adiposity, is a strong determinant of insulin resistance, this 198 
may not be as important in the development of T2DM in Black populations as it is in other ethnic groups 199 
(62). 200 
Ectopic fat, defined as the deposition of triglycerides within cells of non-adipose tissue, is believed to 201 
be integral to the development of T2DM by causing metabolic disturbances in the organ/tissue it resides 202 
in (63). Visceral, liver and pancreatic fat are important ectopic depots. Ethnic specific patterns of ectopic 203 
fat have not been well investigated. In European populations liver fat has been shown to consistently 204 
correlate with measures of insulin resistance. South Asian populations have consistently been shown to 205 
exhibit elevated liver fat (59, 64) but there is a paucity of data regarding pancreatic lipid. In Black 206 
populations the majority of studies have been conducted in adolescent cohorts, with a focus on obese 207 
populations without diabetes (65, 66). Visceral fat, liver and pancreatic fat have been reported to be 208 
lower in Black populations compared to their White counterparts (65, 67). In a review of ethnic 209 
differences in the prevalence of non-alcoholic fatty liver disease (NAFLD), Pan et al. found several 210 
studies consistently reporting a significantly lower prevalence of NAFLD in Black compared to White 211 
populations (68). However, there is evidence that Black populations may be more sensitive to the 212 
negative effects of liver fat accumulation (65). In adults contradictory findings have been reported; liver 213 
fat has been found to be inversely associated with hepatic insulin sensitivity in Black but not White 214 
women (69), however, the opposite was found in Black versus White men where liver fat was inversely 215 
associated with hepatic insulin sensitivity in White but not Black men (70). This suggests that not only 216 
are there ethnic disparities but there are gender differences in the role of ectopic fat in the 217 
pathophysiology of T2DM within the Black ethnic groups where further research is required. Overall, 218 
studies of ectopic fat accumulation show that these features identify a subset of individuals at increased 219 
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risk of T2DM and CVD, although these relationships are affected by ethnicity. Data across different 220 
ethnicities highlight differences in the pathogenesis of insulin resistance.  221 
Glycaemic control, diabetes complications and mortality 222 
Hyperglycaemia is an important risk factor for the development of diabetic microvascular complications 223 
(71); HbA1c has been established as a sensitive marker of glycaemic control and microvascular risk. 224 
However there is concern over the use of HbA1c both for monitoring glycaemic control and in the 225 
diagnosis of diabetes in some ethnic groups because higher HbA1c values, in the region of 0.4%, have 226 
been consistently reported, particularly among Black African/Caribbeans, at all levels of glycaemia (72, 227 
73). In the recent South London Diabetes Study, HbA1c was significantly higher in Black 228 
African/Caribbean people with newly diagnosed T2DM compared to White-Europeans (74). Paul et al. 229 
(2017) also recognised significantly higher HbA1c, and a greater proportion of people with HbA1c ≥ 230 
58 mmol/mol, among Black African-Caribbean participants compared to South Asians or White-231 
Europeans (8). In a longitudinal analysis of 24,111 adults from inner London, ethnicity was 232 
independently associated with HbA1c, and both South Asian and Black African/Caribbean adults 233 
demonstrated worse glycaemic control despite more intensive management (75). Ethnic differences in 234 
HbA1c are proposed to be, at least in part, due to non-glycaemic factors such as variation in glycation 235 
rates and erythrocyte membrane permeability to glucose (76). However, glycated albumin and 236 
frutosamine, which are less affected by non-glycaemic factors, have been shown to also be higher in 237 
non-White European groups (72), suggesting real differences in glycaemic control and an important 238 
contributor to the development of complications and poor outcomes for these ethnic groups. Currently 239 
ethnic-specific HbA1c criteria are not in use, however, a growing body of evidence suggests that 240 
diagnostic and monitoring cut-points should be used with caution in non-White European groups, as 241 
misdiagnosis is significantly more common than in White populations (76).  242 
Whether ethnic differences in mortality and rates of microvascular and macrovascular complications 243 
exist in diabetes has been addressed in a number of large cohorts, for example the UKPDS (77, 78) and 244 
the Southall Diabetes Study (79, 80). In their systematic review of 51 studies Lanting et al. (81) 245 
described distinct differences in the conclusions drawn from US and UK based studies. In the US rates 246 
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of mortality and risk of lower limb amputation, retinopathy, nephropathy and end stage renal disease 247 
are consistently higher amongst non-White European ethnic groups. However, in the UK this is not the 248 
case, compared to White-Europeans, Black African/Caribbean and South Asians have been found to 249 
have lower risks of lower limb amputation (82, 83), equal rates of retinopathy in Black 250 
African/Caribbean (79) and lower rates in South Asians (84), lower rates of cardiovascular 251 
complications in Black African/Caribbean and lower or equal rates in South Asians (79, 84). It is only 252 
nephropathy and end stage renal disease for which the rates are worse in South Asians (84, 85) but equal 253 
in Black African/Caribbeans (79). Although there are cultural differences between ethnic groups living 254 
in the US and the UK, these differences in mortality and morbidity cannot be attributed to genetic 255 
differences, and much more likely point towards differences in healthcare systems, access and quality 256 
of care (81). More recently ethnic differences in diabetes complications have been investigated using 257 
data from the UK THIN database (86). At diagnosis the rates of comorbidities were 30% in White-258 
Europeans compared with 11% of African-Caribbeans and South Asians (86). Clear distinctions in the 259 
incidence of chronic kidney disease (CKD) have been found, which is higher in White-Europeans than 260 
both Black African-Caribbeans and South Asians (86). Ethnic differences in the incidence of major 261 
cardiovascular diseases are also apparent; coronary heart disease (CHD) is highest among South Asians, 262 
while Black African-Caribbeans experience significantly lower rates of CHD compared to White-263 
Europeans and South Asians, but rates of stroke do not differ by ethnicity (86, 87). Detailed 264 
investigations in the SABRE cohort are providing evidence for the mechanisms which may underlie 265 
these ethnic patterns in cardiovascular diseases. For example, arterial stiffness has recently been 266 
reported to be more favourable among Black compared to South Asians, which may explain some of 267 
the relative protection from coronary heart disease experienced by UK Black African/Caribbean groups 268 
(88). In a focus on CHD among South Asians Park et al. recently reported the detrimental impact of 269 
hyperglycaemia on left ventricular failure in South Asians that is not seen in White-Europeans (89).  270 
Healthcare access and engagement 271 
Cultural barriers to accessing healthcare make an important contribution to ethnic inequalities in 272 
diabetes. Linguistic and cultural differences, poor health literacy, low socioeconomic position and their 273 
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migrant status (90) often result in people from non-White European ethnic backgrounds having poorer 274 
diabetes knowledge and worse diabetes control (81). The UK National Service Framework for Diabetes 275 
recognises that diabetes services must be equitable to meet the needs of the population and to narrow 276 
the inequalities gap for groups with the  poorest outcomes (91).  The recent Department of Health (DH) 277 
strategy for the management of long-term conditions highlights the need to promote patient involvement 278 
and self-management (92) and the National Institute for Health and Care Excellence (NICE) 279 
recommends self-management education is accessible for all people with diabetes, taking into account 280 
culture and ethnicity (93). In pursuit of this diabetes services principally aim to deliver patient-centred 281 
care that is responsive to individual culture, lifestyle and religion, which will empower and enable 282 
people to self-manage their diabetes through support and education (91).  However, evidence from the 283 
Healthcare Commission suggests that people from non-White European ethnic backgrounds are more 284 
likely to report not having the opportunity to attend an education course, suggesting that access issues 285 
are impacting on these groups disproportionately (94). Poor access to healthcare is a significant issue 286 
for non-White European ethnic groups (90); the DH report ‘No patient left behind’ was commissioned 287 
in response to findings that people from non-White European ethnic backgrounds find it more difficult 288 
to access primary care services than White populations and their healthcare needs are not met by current 289 
services (95). 290 
Self-management programmes and diet/lifestyle advice, which form the cornerstone of diabetes care, 291 
are less effective in people from non-White European ethnic backgrounds (96). This is often attributed 292 
to a lack of cultural competency amongst healthcare practitioners, and a failure to account for cultural 293 
beliefs and practices in generic education programmes (97). Culturally tailored advice and education 294 
programmes that are respectful of, and responsive to, the health beliefs, practices, cultural and linguistic 295 
needs of diverse people have been developed to overcome issues relating to healthcare access in people 296 
from non-White European ethnic backgrounds, and have been shown to bring about positive health 297 
outcomes (97). Furthermore ensuring cultural competency of healthcare professionals, such that they 298 
understand and can address the customs, beliefs and values of people from different cultural 299 
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backgrounds is proposed as a principal way to address ethnic inequalities in diabetes and its 300 
management (98).  301 
Health behaviour contributors to ethnic disparities in diabetes  302 
It is recognised that among any ethnic group there is huge diversity in terms of health beliefs and 303 
behaviours and ‘culture’ is an ever-changing concept; this is particularly true among different 304 
generations of migrant groups, who may undergo significant acculturation. However, a wealth of 305 
evidence exists which describes distinct cultural beliefs and behaviours that exist amongst non-White 306 
European ethnic groups and can act as barriers to healthful self-management practices. Consideration 307 
of these is important when delivering education programmes and promoting self-management practices 308 
amongst these patient groups. In South Asian communities language and communication discordance 309 
is often focused on as a significant barrier to receiving and understanding diabetes education. However, 310 
there are a number of deeper cultural structures, which may act as stronger barriers, and may not receive 311 
enough focus. Themes reported in the literature include, for example, a strong preference for traditional 312 
remedies and folk medicine, and a concern over the long-term safety of conventional medicines; beliefs 313 
that management should be left to qualified health professionals, a reliance on physician-led advice and 314 
a reluctance to partake in self-management; fatalist beliefs and the view that diabetes is not something 315 
to be concerned about, or it is inevitable, due to its widespread nature; risk being attributed to external 316 
influences e.g. stress, heredity, ‘the will of God/Allah’ for which the person with diabetes has a lack of 317 
control; beliefs that excess weight indicates good health; social responsibilities to maintain a traditional 318 
diet and misconceptions about the principles of the ‘diabetic diet’; a lack of gender specific exercise 319 
facilities, a fear of injury or worsening health with exercise, and exercising being seen as a selfish 320 
activity that detracts from family commitments (99-102). These beliefs may be more relevant among 321 
older generations, those who are less acculturated, or those who associate more closely to traditional 322 
cultural practices. 323 
In African-Caribbean communities, where language discordance may not be a prominent barrier to 324 
receiving health education, important cultural beliefs and behaviours are still recognised that should be 325 
considered. Themes reported in the literature include, for example, a strong distrust of medical advice 326 
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and a desire for natural, non-pharmacological therapies (103). Healthcare professionals are perceived 327 
commonly as lacking cultural understanding (104) and their advice lacking cultural relevance (105) or 328 
being poorly adapted to cultural needs (103). In addition, specific barriers associated with applying 329 
dietary advice to cultural foods consumed at home, an acceptance of larger body sizes and a lack of 330 
cultural salience of engagement in moderate or vigorous physical activity can limit positive health 331 
behaviours (106). Again, there may be generational differences in these beliefs and practices that have 332 
yet to be recognised in the literature. 333 
Diabetes health education that has been culturally-tailored or is culturally appropriate brings about 334 
significantly greater improvements in glycaemic control, diabetes knowledge and self-efficacy than 335 
conventional education (107). However, it is noteworthy that very few culturally-tailored programmes 336 
have been evaluated in the UK. Only four out of the 33 trials included in the recent Cochrane review 337 
were UK-based, and they all focused on South Asian communities using linguistic adaptations (108-338 
111). Effective methods of culturally tailoring have been identified in a recent systematic review (112) 339 
and include:  340 
• Bilingual/bicultural professional educators or lay educators providing the education 341 
• Teaching/counselling about dietary change by modifying ethnic foods and recipes 342 
• Teaching/counselling of activity change using culturally appropriate activities e.g. dancing 343 
and walking 344 
• Delivery of intervention in preferred language, including all materials 345 
• Attendance by family members to elicit home-based support 346 
• Use of visual aids to tailor to low-literacy needs 347 
Diabetes Prevention 348 
Diabetes prevention, targeting specific ethnic groups, has been evaluated in large scale trials and shown 349 
to be effective in indigenous communities in India (113, 114) and China (115). Definitive trials of 350 
T2DM prevention focusing on high-risk migrant populations have yet to be conducted; instead smaller 351 
scale studies have focused on prevention indirectly through weight loss rather than incident diabetes. 352 
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Achievement of weight loss amongst non-White European ethnic groups is noted as particularly 353 
challenging; a range of cultural beliefs and practices relating to body size and weight often act as barriers 354 
to behaviour change (116). For example, African-Americans participating in the Diabetes Prevention 355 
Programme and other weight loss trials achieve approximately half the magnitude of weight loss than 356 
that achieved by White-Americans (116, 117). While in a large scale trial of UK South Asians the 357 
authors noted that weight loss, although significant, was relatively modest (118), and another trial failed 358 
to achieve significant results (119). Understanding how to effectively engage high risk groups, such as 359 
ethnic minority communities, in health promotion interventions has been receiving increasing attention 360 
in recent years as tackling health inequalities has become a public health priority. Community 361 
engagement approaches have advanced as a promising strategy, the evidence for which has been 362 
comprehensively reviewed by O’Mara-Eves et al. (120). Community engagement methods are defined 363 
as ‘involving communities in decision-making and in the planning, design, governance and delivery of 364 
services’ (120). Community engagement approaches can take many forms including service user 365 
networks, volunteering or interventions delivered by trained peers. In their review O’Mara-Eves et al. 366 
concluded that there is strong evidence that community engagement interventions have a positive 367 
impact on health behaviours, health consequences, self-efficacy and perceived social support outcomes 368 
across a range of conditions and should therefore be incorporated into public health intervention design 369 
(120). It is acknowledged, however, that there is little data on the cost effectiveness of such strategies 370 
as they have rarely been evaluated against standard models of care. One example of this approach that 371 
has been evaluated in diabetes prevention is working in partnership with community organisations such 372 
as churches and faith-based institutions, which can overcome issues of distrust associated with 373 
healthcare settings. Faith-based diabetes prevention programmes have been evaluated in the USA and 374 
demonstrated significant improvements in weight, BMI, fasting glucose and healthy nutrition and 375 
activity behaviours (121, 122) but these approaches have yet to be trialled in the UK in which the role 376 
churches and faith institutions play in society is different to the US. 377 
Conclusion 378 
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T2DM is a major public health priority, currently affecting over 3 million individuals in the UK. Non-379 
White European ethnic groups are disproportionately burdened by T2DM; prevalence is alarmingly 380 
high, and it is diagnosed some 10-12 years earlier than in White-Europeans.  These disparities are driven 381 
by a complex interplay of biological, lifestyle, social, clinical and health system factors. Tackling ethnic 382 
inequalities in diabetes requires cultural competency among healthcare professionals and culturally-383 
sensitive interventions that are tailored to the health beliefs and practices of these cultural groups.  384 
17 
 
FIGURE LEGENDS 385 
Figure 1. Ethnic groups, England and Wales Census 2011. Reproduced from Office for National 386 
Statistics.  387 
Figure 2. Doctor-diagnosed type 2 diabetes among ethnic minority groups in England & Wales. 388 
Reproduced from Health Survey for England focus on ethnic minority health, 2004. 389 
Figure 3. Age distribution of people with type 2 diabetes in White-European, African-Caribbean 390 
and South Asian ethnic groups in the UK. Reproduced from Paul SK et al. Diabetes, Obesity & 391 
Metabolism. 2017;19(7):1014-23. 392 
Figure 4. Prevalence of obesity amongst ethnic groups in England and Wales. Reproduced from 393 
Health Survey for England focus on ethnic minority health, 2004. 394 
 395 
 396 
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